Introduction
Thrombotic microangiopathy (TMA)/thrombotic thrombocytopenic purpura (TTP) typically presents with varying degrees of the pentad of Coombs-negative hemolytic anemia, thrombocytopenia, acute renal failure, neurological disturbances, and fever [1] . Several potential causes have been identiWed in this setting; however, no absolute cause has yet been proven.
Monoclonal gammopathy of undetermined signiWcance (MGUS) has been reported in association with several nonmalignant disorders, including autoimmune disorders [2] . MGUS also occurs in patients with Sjögren's syndrome (SS), being detected in 22% of patients in whom immunoelectrophoresis was performed [3] . The present report describes a Japanese patient with TMA and IgM MGUS, which developed 13 years after the diagnosis of primary SS.
Case report
A 61-year-old Japanese woman, who was diagnosed with primary SS 13 years earlier, complained of general fatigue and edematous eyelid. Laboratory blood examination showed thrombopenia, hypergammaglobulinema, and elevation of creatinine, while the urine test showed a protein concentration of 1 g/dl and numerous red blood cells (RBCs) in each microscopic Weld. She was admitted to our hospital for further evaluation.
On admission, physical examination revealed petechial purpura on the lower thigh. Laboratory investigations revealed the following: hemoglobin (Hb) 8.6 g/dl, white blood cell count 3.8 £ 10 3 / l (neutrophils 58%, lymphocytes 31%, monocytes 9%, and eosinophils 1%), platelet count (PLT) 58 £ 10 Immunological studies showed the following: antinuclear antibody 1:80, anti-dsDNA antibody 0.5 IU/ml, anti-Sm antibody 2.5 U/ml, anti-SS-A antibody 129 U/ml, anti-SS-B antibody 38 U/ml, IgG 3,300 mg/dl (33,000 g/l), and IgM 1,140 mg/dl (11,400 g/l). Anti Jo-1 antibody was negative. ImmunoWxation revealed a monoclonal protein, IgM.
Complement C3 was 63.7 mg/dl (normal 60-115 mg/ dl), C4 was 45.1 mg/dl (normal 15-50 mg/dl), and CH50 was 28.5 U/ml (normal 25-50 U/ml). The following test results were all negative: direct and indirect Coombs test, cryoglobulin, proteinase-3 anti-neutrophil cytoplasmic autoantibodies (PR3-ANCAs), myeloperoxidase antineutrophil cytoplasmic autoantibodies (MPO-ANCAs), and anti-glomerular basement membrane (GBM) antibody.
The three tests for the detection of antiphospholipid antibodies (APA) lupus anticoagulant (LA) activity, and anticardiolipin antibodies and anti-2-glycoprotein I antibody (both IgG and IgM) were all negative.
We showed the clinical course of the present patient (Fig. 1 ). ImmunoWxation revealed a monoclonal protein of IgM; however, the bone marrow smear did not show abnormalities toward multiple myeloma and Waldenstöm's macroglobulinemia; therefore, methylprednisolone pulse therapy (500 mg/day for 3 days) was introduced on hospital day 6. Oral 30 mg of prednisolone was also given daily in conjunction with low-molecular-weight heparin (2,000 U/ day). Renal dysfunction did not improve and renal biopsy on hospital day 12 showed Wbrin thrombi in the glomeruli and arterioles, indicating TMA (Fig. 2) . No immune deposits were shown by electron microscopy or by immunoXuorescence microscopy. Further serum analysis revealed a reduced A Disintegrin And Metalloprotease with ThromboSpondin repeats-13 (ADAMTS13) metalloproteinase level of 21.8% (normal 66-126%), but with the absence of anti-ADAMTS13 IgG autoantibodies. Based on these Wndings, the present case was diagnosed as TMA/TTP leading to acute renal failure through ischemia. We decided to initiate therapeutic plasma exchange (on hospital days 30, 32, 35) and strengthened anticoagulation therapy. After these treatments, the patient recovered from these manifestations, and the levels of Hb, PLT, LDH, and creatinine were all normalized, and the patient was discharged on hospital day 65.
Discussion
Renal involvement is often seen in patients with pSS. The most frequent renal complication in SS is tubulointerstitial nephritis. In addition, glomerular immune complex deposits were initially suspected to associate with renal failure in the present case [4] . Unexpectedly, the results of renal Fig. 1 The clinical course of the present patient. The graphs display the hemoglobin, platelets, LDH, and creatinine values and the treatment interventions during the hospital course. (PSL prednisolone; LMWH Lowmolecular-weight heparin) biopsy revealed Wbrin thrombi in the glomeruli and arterioles in the absence of immune deposits, which is characteristic of TMA/TTP. The involvement of larger vessels, such as arteries or veins, in the renal biopsy specimens suggested APS nephropathy [5] . However, she did not meet the classiWcation criteria for antiphospholipid syndrome (APS) [6, 7] , since no APA was found in the serum.
Recent studies indicate that the severe deWciency of a VWF-cleaving metalloproteinase, ADAMTS13, is the main cause of platelet thrombosis in TMA/TTP [8, 9] . In our case, low ADAMTS13 activity and the presence of schistocytosis may suggest ADAMTS 13-related TMA/TTP rather than APS in the present case. In addition, MGUS may additionally contribute to the development of TMA/TTP through hyperviscosity or excess antibody production against unknown targets.
A quick diagnosis of TMA/TTP, which is a potentially lethal condition, made it possible to treat the present case successfully. Thus, we would like to emphasize the importance of performing renal biopsy in patients with collagen disease who present acute renal dysfunction and thrombocytopenia simultaneously. The use of low-molecularweight heparin was thought to be eVective for treating thrombi in the kidney. Plasma exchanges in combination with corticosteroids also appeared to be eVective in reducing immunoglobulin and autoantibodies, which may contribute to TMA/TTP.
In summary, we presented a rare case of pSS complicated with severe renal TMA/TTP following MGUS. Although the pathophysiological mechanism remains to be precisely determined, we could successfully treat the present case based on appropriate and prompt pathological diagnosis. 
